Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

KURA holding history

Kura Oncology, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

KURA overviewAll 13F holders of KURAFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of KURA by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−140,713−100.0%Sold outHolders
Q2 2025140,713$811.9K<0.1%−278,275−66.4%ReducedHolders
Q1 2025418,988$2.77M<0.1%−732,207−63.6%ReducedHolders
Q4 20241,151,195$10.0M<0.1%+727,987+172.0%AddedHolders
Q3 2024423,208$8.27M<0.1%+47,474+12.6%AddedHolders
Q2 2024375,734$7.74M<0.1%−14,168−3.6%ReducedHolders
Q1 2024389,902$8.32M<0.1%+184,282+89.6%AddedHolders
Q4 2023205,620$2.96M<0.1%−1,480−0.7%ReducedHolders
Q3 2023207,100$1.89M<0.1%−5,043−2.4%ReducedHolders
Q2 2023212,143$2.24M<0.1%+42,063+24.7%AddedHolders
Q1 2023170,080$2.08M<0.1%−7,755−4.4%ReducedHolders
Q4 2022177,835$2.21M<0.1%−101,624−36.4%ReducedHolders
Q3 2022279,459$3.82M<0.1%+188,559+207.4%AddedHolders
Q2 202290,900$1.67M<0.1%+27,002+42.3%AddedHolders
Q1 202263,898$1.03M<0.1%−95,036−59.8%ReducedHolders
Q4 2021158,934$2.23M<0.1%+23,929+17.7%AddedHolders
Q3 2021135,005$2.53M<0.1%−164,005−54.8%ReducedHolders
Q2 2021299,010$6.23M<0.1%−48,180−13.9%ReducedHolders
Q1 2021347,190$9.81M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.